End-to-end drug development, specializing in high-potency softgels and liquids, providing global partners with a competitive advantage.
01 1ALLEGRA
02 3ATOVAQUONE
03 1CARBAMAZEPINE
04 1CHILDRENS ADVIL
05 1CHILDRENS ADVIL-FLAVORED
06 1CHILDRENS ALLEGRA ALLERGY
07 1CHILDRENS ALLEGRA HIVES
08 1CHILDRENS FEXOFENADINE HYDROCHLORIDE ALLERGY
09 1CHILDRENS FEXOFENADINE HYDROCHLORIDE HIVES
10 1CHILDRENS IBUPROFEN
11 1CHILDRENS MOTRIN
12 8CLOBAZAM
13 7IBUPROFEN
14 1KIONEX
15 1LOPERAMIDE HYDROCHLORIDE
16 1MEGACE
17 1MEGESTROL ACETATE
18 1MEPRON
19 1NYSTATIN
20 1OXCARBAZEPINE
21 1SODIUM POLYSTYRENE SULFONATE
22 1TERIL
23 1VERSACLOZ
01 120264
02 120500
03 120516
04 220589
05 121963
06 140028
07 162876
08 174916
09 174937
10 174978
11 175671
12 175714
13 176729
14 176925
15 190590
16 191292
17 2201373
18 1202961
19 2203330
20 1203479
21 1205647
22 1208819
23 1209105
24 1209179
25 1209204
26 1209207
27 1209685
28 1209715
29 1210039
30 1210546
31 1210569
32 1210692
33 1210746
34 1211259
35 1213110
01 35No
02 3Yes
End-to-end drug development, specializing in high-potency softgels and liquids, providing global partners with a competitive advantage.
Drug : VERSACLOZ
Dosage Form : SUSPENSION; ORAL
Application Number : 203479
Country : US
Patented : Yes
Strides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.
Drug : MEGESTROL ACETATE
Dosage Form : SUSPENSION; ORAL
Application Number : 75671
Country : US
Patented : No
Drug : IBUPROFEN
Dosage Form : SUSPENSION; ORAL
Application Number : 74978
Country : US
Patented : No
Drug : OXCARBAZEPINE
Dosage Form : SUSPENSION; ORAL
Application Number : 202961
Country : US
Patented : No
Drug : CLOBAZAM
Dosage Form : SUSPENSION; ORAL
Application Number : 208819
Country : US
Patented : No
Drug : MEGACE
Dosage Form : SUSPENSION; ORAL
Application Number : 20264
Country : US
Patented : No
Drug : IBUPROFEN
Dosage Form : SUSPENSION; ORAL
Application Number : 205647
Country : US
Patented : No
Drug : CLOBAZAM
Dosage Form : SUSPENSION; ORAL
Application Number : 211259
Country : US
Patented : No
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Drug : ATOVAQUONE
Dosage Form : SUSPENSION; ORAL
Application Number : 209685
Country : US
Patented : No
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Drug : CHILDRENS MOTRIN
Dosage Form : SUSPENSION; ORAL
Application Number : 20516
Country : US
Patented : No
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
